Bain Capital Life Sciences, Cormorant Asset Management and RA Capital co-led the Staidson-backed inflammatory disease drug developer's latest round.

Lata Hariharan takes an in-depth look at the digital health ecosystem in Israel, finding much to be cheerful about.

The insurer is offering $12,000 in seed funding as part of a new health and welfare accelerator formed in partnership with incubator H-Farm.

ImaginAb, a UCLA spinout that has now raised approximately $4m in total, will continue development of the imaging agent it is developing for T-cell tumours.

Spero Therapeutics, a bacterial infection treatment developer based on research at Harvard Medical School, has filed to raise up to $86.3m in an initial public offering.

University of Toronto Mississauga spinout Janpix has obtained $17.6m in funding from corporate-backed Medicxi, which had seeded the company.

The surgical model developer, based on research at German Sport University College and University Hospital of Cologne, will use the cash to enter North American and Asian markets.

Avizia has acquired Carena, which counted McKesson, Cambia Health Solutions and Catholic Health Initiatives as investors, to form a diverse telehealth platform.